BioMarin Pharmaceuticals
BMRN
BMRN
554 hedge funds and large institutions have $15.2B invested in BioMarin Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 194 increasing their positions, 192 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
8% less call options, than puts
Call options by funds: $153M | Put options by funds: $166M
1.65% less ownership
Funds ownership: 98.95% → 97.3% (-1.6%)
7% less capital invested
Capital invested by funds: $16.3B → $15.2B (-$1.1B)
Holders
554
Holding in Top 10
6
Calls
$153M
Puts
$166M
Top Buyers
| 1 | +$680M | |
| 2 | +$261M | |
| 3 | +$226M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72.2M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$70M |
Top Sellers
| 1 | -$385M | |
| 2 | -$341M | |
| 3 | -$145M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$130M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$118M |